# BioStar Capital

> BioStar Capital is a VC fund backing Medical Device and Health Care. See 52 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Petoskey, United States
- Total investments: 52
- Last investment: Jul 2025
- Lead investor: 35%
- Last fund: Dec 2023
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/biostar-ventures/
- Website: https://www.biostar.capital

BioStar Capital is a VC fund in Petoskey focused on Medical Device and Health Care. BioStar Ventures is a venture capital company that offers private equity investment services to firms in the medical device technology services industries. It was founded in 2003 by Louis Cannon and is based in Michigan.

## Contacts

5 contacts available for BioStar Capital. Shizune tracks 8 team members at BioStar Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/biostar-private-equity?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical Device | 24 | 46% |
| Health Care | 22 | 42% |
| Medical | 14 | 27% |
| Biotechnology | 11 | 21% |
| Manufacturing | 7 | 13% |

13 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 17 | 33% |
| Series C | 7 | 13% |
| Series A | 5 | 10% |
| Series D | 4 | 8% |
| Series F | 2 | 4% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 26 | 50% |
| Israel | 2 | 4% |
| Italy | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Hank Kucheman | Managing Director | 0 | https://shizune.co/investors/profile/hank-kucheman |
| David J. Brophy | Director | 0 | https://shizune.co/investors/profile/david-j-brophy |
| Lisa Riedmiller | Controller | 0 | https://shizune.co/investors/profile/lisa-riedmiller |
| Louis Cannon | Founder & Senior Managing Director | 11 | https://shizune.co/investors/profile/louis-cannon |
| Mark Toland | Partner and EIR | 2 | https://shizune.co/investors/profile/mark-toland |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Field Medical | Field Medical blends passion and experience to advance cardiac care helping physicians, cardiologists, and patients to achieve the best possible outcomes during cardiac ablation procedures. | $35M | Series B | Jul 01, 2025 |  |
| Nectero Medical | Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms. The company was founded in 2017 and is headquartered in Dover, Delaware, United States. | $96M | Series D | Apr 11, 2024 |  |
| MMI | We believe that all patients deserve the most innovative, open surgical treatment options so they can live their fullest lives. We’re on a mission to advance robotic technology that pushes the limits of soft tissue open surgery and opens new opportunities for surgeons to restore quality of life for more patients with complex conditions. TheSymani® Surgical System is a first-of-its kind robotic technology that uniquely addresses the scale and complexities of microsurgery and supermicrosurgery to restore quality of life for more patients. | $110M | Series C | Feb 21, 2024 |  |
| Amplitude Vascular Systems | Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2020 and is based in Ann Arbor, Michigan. | $8.8M | Series B | Apr 04, 2023 |  |
| Amplitude Vascular Systems | Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2020 and is based in Ann Arbor, Michigan. | $8.8M | Series B | Apr 04, 2023 |  |
| Amplitude Vascular Systems | Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2020 and is based in Ann Arbor, Michigan. | $8.8M | Series B | Apr 04, 2023 |  |
| Amplitude Vascular Systems | Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2020 and is based in Ann Arbor, Michigan. | $20M | Series B | Jan 05, 2023 |  |
| Amplitude Vascular Systems | Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2020 and is based in Ann Arbor, Michigan. | $20M | Series B | Jan 05, 2023 |  |
| Amplitude Vascular Systems | Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2020 and is based in Ann Arbor, Michigan. | $20M | Series B | Jan 05, 2023 |  |
| Amplitude Vascular Systems | Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2020 and is based in Ann Arbor, Michigan. | $1.2M | Series A | Oct 26, 2022 |  |

10 of 52 investments shown.

## Co-investors
- [CUE Growth Partners](https://shizune.co/investors/profile/cue-growth-partners) — VC Fund, 4 deals together
- [Deerfield](https://shizune.co/investors/profile/deerfield) — VC Fund, 4 deals together
- [MedFocus Fund](https://shizune.co/investors/profile/medfocus-fund) — VC Fund, 4 deals together
- [Portfolia](https://shizune.co/investors/profile/portfolia) — VC Fund, 4 deals together
- [Safeguard Scientifics](https://shizune.co/investors/profile/safeguard-scientifics) — VC Fund, 4 deals together
- [Triventures](https://shizune.co/investors/profile/triventures) — VC Fund, 4 deals together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does BioStar Capital invest in?

BioStar Capital invests primarily in Medical Device, Health Care and Medical startups, most often at Series B and Series C stage. Most of the 52 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact BioStar Capital?

Public channels for BioStar Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at BioStar Capital?

The team at BioStar Capital includes Hank Kucheman (Managing Director), David J. Brophy (Director) and Lisa Riedmiller (Controller), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co